Medical Device News

Clinical Trial Equipment & Ancillary Solutions Market Report 2022-2030: Featuring Key Players Ancillare, Imperial, Thermo Fisher Scientific & Others

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

The “Clinical Trial Equipment & Ancillary Solutions Market Size, Share & Trends Analysis Report by Product (Sourcing, Supply/Logistics), by Phase (Phase I, II, III, IV), by Region (APAC, North America), and Segment Forecasts, 2022-2030″ report has been added to ResearchAndMarkets.com’s offering.

The global clinical trial equipment & ancillary solutions market is expected to reach USD 5.09 billion by 2030, expanding at a CAGR of 8.1% over the forecast period. The growing pharmaceutical and medical sectors, globalization of clinical trials, and rising R&D expenditure are the factors driving the market.

The clinical trial procedure has evolved considerably in recent years. Complex clinical studies are creating new problems throughout the healthcare supply chain. Modern studies frequently involve huge numbers of patients and patient subgroups, as well as numerous nations and research sites.

As a result, the number of challenges that supply chain managers confront while working with clinical trial equipment & ancillaries has increased. Renting medical equipment relieves the burden of storage, retrieval, and disposal. Another important decision-making reason is that renting equipment reduces significant upfront expenses and large investments required to furnish licensed clinical trial locations.

Clinical Trial Equipment & Ancillary Solutions Market Report Highlights

  • The supply/logistics product segment dominated the market with a revenue share of more than 38% in 2021 due to the high number of clinical trials globally, which resulted in increased demand for efficient logistics services.
  • The phase III segment accounted for the maximum revenue share of 53.9% in the global market in 2021. Phase III studies are the most effective approach to discovering a new treatment standard.
  • North America led the global market in 2021 and is expected to remain dominant even during the forecast years due to a rise in the number of CRO and pharmaceutical & medical companies in the region.
  • Asia Pacific is projected to be the registered fastest-growing CAGR of 9.5% during the forecast period as it is becoming an increasingly significant site for clinical trial investigations.

Key Topics Covered:

Chapter 1 Methodology and Scope

Chapter 2 Executive Summary

Chapter 3 Clinical Trial Equipment & Ancillary Solutions Market: Variables, Trends, & Scope
3.1 Market Lineage Outlook
3.1.1 Parent Market Outlook
3.1.2 Ancillary Market Outlook
3.2 Penetration & Growth Prospect Mapping
3.3 Market Dynamics
3.3.1 Market Driver Analysis
3.3.1.1 Evolving Clinical Trials Needs
3.3.1.2 Rising Investment In R&D
3.3.1.3 Growing Pharmaceutical & Medical Devices Industry
3.3.2 Market Restraint Analysis
3.3.2.1 Rising Cost Of Clinical Trials

Chapter 4 Clinical Trial Equipment & Ancillary Solutions Market: Product Segment Analysis

Chapter 5 Clinical Trial Equipment & Ancillary Solutions Market: Phaseanalysis

Chapter 6 Clinical Trial Equipment & Ancillary Solutions Market: Regional Analysis

Companies Mentioned

  • Ancillare Lp
  • Imperial Crs
  • Woodley Equipment Company Ltd
  • Thermo Fisher Scientific Inc.
  • Ppd, Inc
  • Parexel International Corporation
  • Medicapital Rent (Emsere)
  • Quipment Sas
  • Irm
  • Marken a Ups Company
  • Myonex
  • Yourway

For more information about this report visit here.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Ultrahuman Announces its App Store ‘PowerPlugs’ with the World’s First AFib Detection Technology on a Smart Ring

Recognizing each individual’s health journey is unique, PowerPlugs enable people to choose and focus on the aspects of their health that matter most. It’s designed for highly personalized health insights, ensuring that every individual can personalize their health tracking to their unique needs and goals.

VisionAir Solutions Celebrates Milestone and New Collaboration

This achievement marks VisionAir Solutions commitment to bringing technological innovation to pulmonary medicine. Since its acquisition by Theken Companies last year, VAS has over doubled its growth and continues to demonstrate industry adoption and the advantages of personalized healthcare.

Valencia Technologies Announces CMS Publication of 2025 Medicare Proposed Rule for eCoin® Procedure

Ann Decker, VP of Reimbursement for Valencia Technologies, stated, "The cumulative effect of the proposed 2025 continuation of APC assignment 5464, the improved ASC payment rate, and the recognition of ITNS as a minimally invasive OAB treatment option in the recently updated guidelines by the American Urological Association (AUA) and the Society of Urodynamics, Female Pelvic Medicine, and Urogenital Reconstruction (SUFU), underscores that the eCoin ITNS system will have a strong reimbursement pathway throughout 2025 and beyond.